LAS VEGAS, May 28, 2008 (PRIME NEWSWIRE) -- Cardio Infrared Technologies, Inc. (Pink Sheets:CIRT), a leading Health and Wellness technology and marketing company, announced today results of the mid-Clinical Trials and the promotion of Carol Anglin to the position of National sales director.
Wayne Bailey, President and CEO of Cardio Infrared Technologies, Inc. stated, "The promotion of Carol Anglin to the position of National Sales Director for Cardio Infrared Technologies, Inc. will allow the continued aggressive pursuit of all sales leads that has and is leading to an ever expanding record of closed sales for Cardio-Cor unit. Carol joined the Cardio-Cor team in November 2006. Carol started working with Cardio Infrared Technologies, Inc. doing cold calls in the Utah market. Carol quickly completed sales of two units by the end of 2006. In 2007 she was doing cold calls on a nationwide basis developing sales leads and sales first on the East Coast and then on the West Coast. Carol has become a very valuable member of the Cardio-Cor sales and management team. The training she has received and the first hand observations of the results obtained by the public using the Cardio-Cor has given her a unique perspective that has added to the mounting sales momentum of Cardio Infrared Technologies, Inc. Carol was part of the team that attended the Anti-Aging show in December 2007 and was given the responsibility for the sales leads generated from that show. Carol has aggressively followed up on the leads generated by the shows, which has resulted in many sales that may have been missed if not for her conscientiousness. Carol Anglin came to Cardio Infrared Technologies, Inc. with over 25 years of sales experience which includes selling photography, Tanning equipment and Time Shares. Carol has a strong desire to help people gain a healthier and more natural way of improving their lives. Carol's son Scott died of bone cancer at age 20 which led her to a quest to find other alternative ways to keep the body in a natural healthy state of being."
Wayne Bailey, President and CEO of Cardio Infrared Technologies, Inc. further commented, "The preliminary results from the Clinical Trials are very encouraging and have resulted in an expansion of clinical trials to include additional health aspects that were not included in the original clinical trial outline. This expansion is a very exciting development for the future of the Cardio-Cor unit because it will expand the market and improve the demand for the units not only this year but for many years to come. Many shareholders of Cardio Infrared Technologies, Inc. are professional health care providers and they have recognized the benefits of using infrared technology for healing and are eagerly awaiting the final results of the Clinical trials."
Clinical Trials are expected to be completed in late 3rd Q.
About Cardio Infrared Technologies, Inc.
Cardio Infrared Technologies, Inc is a technology and marketing company, which is focused on developing the revolutionary and evolutionary process of combining exercise equipment with medical benefits that go far beyond the normal benefits of standard exercise equipment. Cardio Infrared Technologies, Inc. is committed to continue to market this equipment to the exercise and medical markets and to aggressively expand the market to every country around the world. The equipment has already been featured on Good Morning America and The View. Cardio Infrared Technologies, Inc. also has an aggressive growth plan that includes acquisitions and development of innovate new equipment in the exercise and medical industries.
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.The words or phrases "would be," "would allow," "intends to," "will likely result," "are expected to," "will continue," "anticipate," "expect," "estimate," "project," "indicate," "could," "potentially," "should," "believe," "considers," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties. These include the company's historic lack of profitability, end user customer acceptance and actual demand, which may differ significantly from expectations, the need for the company to manage its growth, the need to raise funds for operations and other risks within the regulation of the industry. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation, to update any forward-looking statements to reflect occurrences, developments, events or circumstances after the date of such statement.